In pancreatic cancer, adrenergic signaling to tumor cells induces nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) release by tumor cells, resulting in increased nerve density in the tumor area. This evidence concerns the gene NGF and familial pancreatic carcinoma.